| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |